News • February 23, 2023
Beth Israel Deaconess Medical Center (BIDMC) is rolling out a patient reported outcomes assessment platform that will gather valuable information across the entire spectrum of its orthopedic care providers.
The Musculoskeletal Translational Innovation and Initiative (MTII) at Beth Israel Deaconess Medical Center’s Carl J. Shapiro Department of Orthopaedic Surgery creates an environment to foster and promote disruptive and innovative solutions for medical care, regardless of specialty field, to be translated into medical devices, clinical protocols, therapeutics, or diagnostics.
The Bouxsein group employs a multidisciplinary strategy with state-of-the-art technologies to study the causes, detection and treatment of skeletal fragility. Our ultimate goal is to reduce the burden of fractures due to osteoporosis and other bone disorders.
